Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-26-022384
Filing Date
2026-05-12
Accepted
2026-05-12 07:00:50
Documents
79
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 810000
2 EX-31.1 ex31-1.htm EX-31.1 17606
3 EX-31.2 ex31-2.htm EX-31.2 17577
4 EX-32.1 ex32-1.htm EX-32.1 8301
5 EX-32.2 ex32-2.htm EX-32.2 8324
  Complete submission text file 0001493152-26-022384.txt   5883475

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE nrxs-20260331.xsd EX-101.SCH 46754
7 XBRL CALCULATION FILE nrxs-20260331_cal.xml EX-101.CAL 70334
8 XBRL DEFINITION FILE nrxs-20260331_def.xml EX-101.DEF 185854
9 XBRL LABEL FILE nrxs-20260331_lab.xml EX-101.LAB 423916
10 XBRL PRESENTATION FILE nrxs-20260331_pre.xml EX-101.PRE 341946
82 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 789141
Mailing Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032
Business Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032 (812) 689-0791
Neuraxis, INC (Filer) CIK: 0001933567 (see all company filings)

EIN.: 455079684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41775 | Film No.: 26965812
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)